Singing by boys ’ choir ‘sounds more brilliant’ when girls in audience
Just as frogs and crickets alter calls to attract mates, study shows male singers boost vocals in front of female onlookersBehind the rousing song of an all-male choir lies an evolutionary force that is better known for shaping the sex lives of hopeful frogs and crickets, research suggests.Recordings of an elite boys ’choir once directed by Johann Sebastian Bach in Leipzig, Germany, reveal that the more physically mature boys in the group boosted their vocals with an appealing ring when girls were in the audience.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 8, 2023 Category: Science Authors: Ian Sample Science editor Tags: Science Music Neuroscience Choral music Source Type: news
Study shows that a single neuron ’s parallel outputs can coordinate many aspects of behavior
A new MIT study funded by the U.S. National Science Foundation focuses on a single cell in one of nature ’s simplest nervous systems. It provides an in-depth illustration of how individual neurons can use multiple means to drive complex behaviors.In… (Source: NSF News)
Source: NSF News - November 7, 2023 Category: Science Authors: NSF Source Type: news
Understanding the science of addiction – podcast
After Matthew Perry ’s death was announced, a clip of the actor debating the science of addiction on the BBC’s Newsnight programme went viral. To find out where we’ve got to in our understanding of addiction, Ian Sample talks to Dr Nora Volkow, director of the US National Institute on Drug Abuse. She explains how brain imaging has advanced our understanding of this chronic diseaseClips: NBC, BBCContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 7, 2023 Category: Science Authors: Presented by Ian Sample; produced by Joshan Chana; sound design by Mau Loseto; the executive producer is Ellie Bury Tags: Science Opioids Health Medical research Society Psychology Neuroscience Source Type: news
Spinal implant allows Parkinson's patient to walk again in world first – video
The first patient to receive a spinal implant to treat advanced Parkinson's disease has described experiencing 'a rebirth' after the treatment allowed him to walk again without falling over. Marc, 63, from Bordeaux, France, was diagnosed with the degenerative disease more than 20 years ago and had developed severe mobility problems, including balance impairments and freezing of gait. After receiving the implant, which aims to restore normal signalling to the leg muscles from the spine, he has been able to walk more normally and regained his independence.Parkinson ’s patient able to walk 6km without problems after spinal ...
Source: Guardian Unlimited Science - November 6, 2023 Category: Science Authors: Maximilian Jenz Tags: Parkinson's disease Neuroscience Health Medical research World news Source Type: news
Parkinson ’s patient able to walk 6km without problems after spinal implant
Marc, 63, had freezing of gait before becoming first with advanced Parkinson ’s to be fitted with device restoring normal signallingThe first patient to receive a spinal implant to treat advanced Parkinson ’s disease has described experiencing “a rebirth” after the treatment allowed him to walk again without falling over.Marc, 63, from Bordeaux, France, was diagnosed with the degenerative disease more than 20 years ago and had developed severe mobility problems, including balance impairments and freezing of gait. After receiving the implant, which aims to restore normal signalling to the leg muscles from the spine,...
Source: Guardian Unlimited Science - November 6, 2023 Category: Science Authors: Hannah Devlin Science correspondent Tags: Parkinson's disease Neuroscience Health Medical research Source Type: news
How AI Is Shaping Scientific Discovery
A recent workshop at the National Academies explored the present and future of artificial intelligence in advancing discovery across a range of scientific fields, from physics to neurology to meteorology. (Source: News from the National Academies)
Source: News from the National Academies - November 6, 2023 Category: Science Source Type: news
Researchers find the roots of tau tangles in Alzheimer ’s disease
An experimental drug can reduce the toxic changes in tau proteins known to damage neurons in brains with Alzheimer ’s disease, researchers report. (Source: Yale Science and Health News)
Source: Yale Science and Health News - November 3, 2023 Category: Universities & Medical Training Source Type: news
Neuroscience for Athletes Launches, Unleashing the Power of the Mind for Peak Performance
Neuroscience for Athletes, a groundbreaking platform at the intersection of neuroscience, cognitive science, artificial intelligence, psychology, and statistics, has officially launched its mission to assist athletes in achieving their peak performance. LAS VEGAS, Nov. 3, 2023... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 3, 2023 Category: Pharmaceuticals Tags: PDT Source Type: news
Rats may have power of imagination, research reveals
Scientists say that like humans the rodents can navigate through a space using only their thoughtsWhether dreaming of a white Christmas or simply pondering how best to rearrange the furniture, humans are able to conjure up myriad situations that are not in front of us. Now it seems rats may be able to do something similar.Researchers have found that rats can navigate their way through a space they have previously explored using their thoughts alone, suggesting the rodents have some sort of imagination.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 2, 2023 Category: Science Authors: Nicola Davis Science correspondent Tags: Science Animals Consciousness Neuroscience World news Source Type: news
Probe of Alzheimer's Researcher Halted; Dementia and Triglycerides; Migraine Genes
(MedPage Today) -- City University of New York temporarily halted its probe into the alleged scientific misconduct of faculty member and Alzheimer's researcher Hoau-Yan Wang, PhD, citing concerns about the integrity of the investigation. (New York... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 1, 2023 Category: Neurology Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces EMBARK trial in Duchenne muscular dystrophy (DMD) did not reach primary endpoint, but shows positive efficacy outcomes on all timed functional key endpoints
This study is ongoing.Study 301 (EMBARK), a Phase 3 global, randomised, double-blinded and placebo-controlled study of Elevidys in ambulatory Duchenne patients aged 4-<8 years old.The ENVOL trial (Study 302) a Phase 2 study in children with Duchenne. The study aims to enrol 21 participants who are under 4 years of age, including newborns. Not yet started.The ENVISION trial (Study 303), a Phase 3 study in older ambulatory/non-ambulatory patients which is now recruiting.The EXPEDITION long-term (5 year) follow up study (Study 305) of participants who have received Elevidys in a previous clinical study, which is not yet re...
Source: Roche Media News - October 31, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces EMBARK trial in Duchenne muscular dystrophy (DMD) did not reach primary endpoint, but shows positive efficacy outcomes on all timed functional key endpoints
This study is ongoing.Study 301 (EMBARK), a Phase 3 global, randomised, double-blinded and placebo-controlled study of Elevidys in ambulatory Duchenne patients aged 4-<8 years old.The ENVOL trial (Study 302) a Phase 2 study in children with Duchenne. The study aims to enrol 21 participants who are under 4 years of age, including newborns. Not yet started.The ENVISION trial (Study 303), a Phase 3 study in older ambulatory/non-ambulatory patients which is now recruiting.The EXPEDITION long-term (5 year) follow up study (Study 305) of participants who have received Elevidys in a previous clinical study, which is not yet re...
Source: Roche Investor Update - October 31, 2023 Category: Pharmaceuticals Source Type: news
AC Immune highlights a-syn PET study
In this study, Hansson and colleagues performed F-18 ACI-12589 PET imaging in 23 participants with a-synuclein related disorders, 11 with other neurodegenerative disorders, and eight controls. The analysis revealed that F-18 ACI-12589 demonstrated clear binding in the cerebellar white matter and middle cerebellar peduncles of MSA patients, regions known to be highly affected by a-synuclein pathology.(a) Transversal images at the level of the middle cerebellar peduncles in a control participant, and patients with dementia with Lewy bodies (DLB), multiple system atrophy-cerebellar subtype (MSA-C), and Parkinson’s disease (...
Source: AuntMinnie.com Headlines - October 30, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Parkinson ’s disease research center being formed at Yale
The new center seeks to reveal the biological underpinnings of Parkinson ’s and advance the delivery of cutting-edge neurosciences research and care. (Source: Yale Science and Health News)
Source: Yale Science and Health News - October 30, 2023 Category: Universities & Medical Training Source Type: news
Race to AI: the origins of artificial intelligence, from Turing to ChatGPT
Today ’s poem-writing AI has ancestry in punch-card machines, trundling robots and godlike gaming enginesIn the winter of 1958, a 30-year-old psychologist named Frank Rosenblatt was en route from Cornell University to the Office of Naval Research in Washington DC when he stopped for coffee with a journalist.Rosenblatt had unveiled a remarkable invention that, in the nascent days of computing, created quite a stir. It was, he declared, “the first machine which is capable of having an original idea”.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 28, 2023 Category: Science Authors: Ian Sample Science editor Tags: Artificial intelligence (AI) Technology Computing Consciousness Neuroscience Alan Turing UK news DeepMind OpenAI IBM Source Type: news
